Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Oct 25;6(20):5655-5658.
doi: 10.1182/bloodadvances.2022006982.

Red cell alloimmunization is associated with increased health care costs, longer hospitalizations, and higher mortality

Elisabet Viayna  1 , Eric A Gehrie  2 , Christopher Blanchette  3 , Geralyn M Meny  4 , Ghislain Noumsi  5 , Maria Huber  6 , M Chris Runken  7
Affiliations

Red cell alloimmunization is associated with increased health care costs, longer hospitalizations, and higher mortality

Elisabet Viayna et al. Blood Adv. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflict-of-interest disclosure: E.V. is an employee of Grifols S.A. E.A.G., and C.B. are consultants to Grifols SSNA. G.M.M., M.H., and M.C.R. are employees of Grifols SSNA. G.N. was employed by Grifols SSNA at the time of project implementation. C.B. is currently an employee of Novo Nordisk Inc.

Figures

Figure 1.
Figure 1.
Median cost per inpatient admission and incremental cost of alloimmunized vs non-alloimmunized groups adjusted by DRG.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Tormey CA, Hendrickson JE. Transfusion-related red blood cell alloantibodies: induction and consequences. Blood. 2019;133(17):1821–1830. - PMC - PubMed
    1. Telen MJ, Afenyi-Annan A, Garrett ME, Combs MR, Orringer EP, Ashley-Koch AE. Alloimmunization in sickle cell disease: changing antibody specificities and association with chronic pain and decreased survival. Transfusion. 2015;55(6 Pt 2):1378–1387. - PMC - PubMed
    1. Vidler JB, Gardner K, Amenyah K, Mijovic A, Thein SL. Delayed haemolytic transfusion reaction in adults with sickle cell disease: a 5-year experience. Br J Haematol. 2015;169(5):746–753. - PubMed
    1. Vichinsky EP, Luban NL, Wright E, et al. Stroke Prevention Trail in Sickle Cell Anemia Prospective RBC phenotype matching in a stroke-prevention trial in sickle cell anemia: a multicenter transfusion trial. Transfusion. 2001;41(9):1086–1092. - PubMed
    1. Ambruso DR, Githens JH, Alcorn R, et al. Experience with donors matched for minor blood group antigens in patients with sickle cell anemia who are receiving chronic transfusion therapy. Transfusion. 1987;27(1):94–98. - PubMed